Early and sustained symptom improvement with umeclidinium/vilanterol versus monotherapy in COPD: a post hoc analysis of the EMAX randomised controlled trial
在慢性阻塞性肺疾病(COPD)治疗中,乌美溴铵/维兰特罗联合治疗较单药治疗可早期且持续改善症状:EMAX随机对照试验的事后分析
期刊:Therapeutic Advances in Respiratory Disease
影响因子:3
doi:10.1177/1753466620926949
Kerwin, Edward M; Boucot, Isabelle H; Vogelmeier, Claus F; Maltais, Francois; Naya, Ian P; Tombs, Lee; Jones, Paul W; Lipson, David A; Keeley, Tom; Bjermer, Leif